Searchable abstracts of presentations at key conferences in endocrinology

ea0081p415 | Pituitary and Neuroendocrinology | ECE2022

Effects of somapacitan on glucose metabolism in adults with GH deficiency

Johannsson Gudmundur , MK Biller Beverly , Fukuoka Hidenori , Ho Ken , Hojby Rasmussen Michael , Nedjatian Navid , Svaerke Claus , CJ Yuen Kevin , Takahashi Yutaka

Somapacitan is a once-weekly, long-acting growth hormone (GH) derivative approved for the treatment of adult GH deficiency (AGHD). Our objective was to evaluate the effects of somapacitan on glucose metabolism compared with daily GH or placebo in patients with AGHD using data from three previously published phase 3 trials: REAL 1 (NCT02229851), REAL 2 (NCT02382939) and REAL Japan (NCT03075644). REAL 1 was a randomised, placebo-controlled (double-blind) and active-controlled (o...

ea0050p327 | Obesity and Metabolism | SFEBES2017

Male sexual dysfunction and hypogonadism improves following bariatric surgery

Ho Jan Hoong , Adam Safwaan , Azmi Shazli , Dhage Shaishav , Liu Yifen , Ferdousi Maryam , Syed Akheel , Ammori Basil , Malik Rayaz , Donn Rachelle , Soran Handrean

Background: Male sexual dysfunction is common in obesity with complex underlying mechanisms. Testosterone replacement has often been initiated in clinical practice in the presence of sexual dysfunction and male obesity-associated secondary hypogonadism. The benefits to sexual functioning, however, are not well documented. The aims of the study were to investigate the relationship between sexual function and hypogonadism in severe obesity and to understand the impact of bariatr...

ea0050p332 | Obesity and Metabolism | SFEBES2017

Reverse cholesterol transport and other functions of high density lipoprotein are enhanced after bariatric surgery

Adam Safwaan , Siahmansur Tarza , Liu Yifen , Azmi Shazli , Siddals Kirk , Ho Jan Hoong , Dhage Shaishav , Malik Rayaz , Syed Akheel , Ammori Basil , Durrington Paul , Donn Rachelle , Soran Handrean

Background: Emerging evidence suggests that impaired high density lipoprotein (HDL) function is associated with cardiovascular disease (CVD). HDL is essential for removing excess circulating cholesterol by reverse cholesterol transport (RCT). Additionally HDL reduces inflammation and oxidative stress, especially through paraoxonase-1. Whereas HDL’s capacity to accept cholesterol from peripheral cells is key (i.e. cholesterol efflux capacity (CEC)), successful RCT depends ...

ea0050p327 | Obesity and Metabolism | SFEBES2017

Male sexual dysfunction and hypogonadism improves following bariatric surgery

Ho Jan Hoong , Adam Safwaan , Azmi Shazli , Dhage Shaishav , Liu Yifen , Ferdousi Maryam , Syed Akheel , Ammori Basil , Malik Rayaz , Donn Rachelle , Soran Handrean

Background: Male sexual dysfunction is common in obesity with complex underlying mechanisms. Testosterone replacement has often been initiated in clinical practice in the presence of sexual dysfunction and male obesity-associated secondary hypogonadism. The benefits to sexual functioning, however, are not well documented. The aims of the study were to investigate the relationship between sexual function and hypogonadism in severe obesity and to understand the impact of bariatr...

ea0050p332 | Obesity and Metabolism | SFEBES2017

Reverse cholesterol transport and other functions of high density lipoprotein are enhanced after bariatric surgery

Adam Safwaan , Siahmansur Tarza , Liu Yifen , Azmi Shazli , Siddals Kirk , Ho Jan Hoong , Dhage Shaishav , Malik Rayaz , Syed Akheel , Ammori Basil , Durrington Paul , Donn Rachelle , Soran Handrean

Background: Emerging evidence suggests that impaired high density lipoprotein (HDL) function is associated with cardiovascular disease (CVD). HDL is essential for removing excess circulating cholesterol by reverse cholesterol transport (RCT). Additionally HDL reduces inflammation and oxidative stress, especially through paraoxonase-1. Whereas HDL’s capacity to accept cholesterol from peripheral cells is key (i.e. cholesterol efflux capacity (CEC)), successful RCT depends ...

ea0086p45 | Endocrine Cancer and Late Effects | SFEBES2022

Emergency Ambulatory Outpatient Management of Immune Checkpoint Inhibitor-mediated Hypocortisolaeamia

Ganawa Shawg , Muhammad Haris , Knight Tom , Dhage Shaishav , Hoong Ho Jan , Gupta Avinash , Lorigan Paul , Higham Claire , Cooksley Tim , Adam Safwaan

Background: Immunotherapy mediated adrenocorticotrpic hormone (ACTH) deficiency is an important toxicity related to immune-checkpoint inhibitors (ICPi) potentially resulting in significant morbidity. Early diagnosis and optimal management are essential and frequently necessitate inpatient hospital treatment. We have previously reported an ambulatory management pathway for ICPi-induced ACTH deficiency in 4 patients. We sought to report the outcomes of this pathway in a larger c...

ea0090ep732 | Pituitary and Neuroendocrinology | ECE2023

Pituitary metastasis in neuroendocrine neoplasms, lesson learned from cases reports

Ganawa Shawg , Ilyas Waqas , Irshad Shadman , Hamad Adeel , Pathmanaban Omar , Milanovic Dusan , Colaco Rovel , Blackhall Fiona , Valle Juan , Ho Jan Hoong , Adam Safwaan

Introduction: Pituitary metastases (PM) are an uncommon manifestation of Neuroendocrine neoplasms (NENs) and are rarely reported. We report two cases of PM with different clinical lessons.Case 1: A 37-year-old female underwent surgical resection for a high grade poorly differentiated neuroendocrine carcinoma of the cervix (Ki67 90%). Serial follow-up surveillance assessments revealed disease progression (local, liver, lung, and bone) for which she underw...

ea0063gp7 | Adrenal and Neuroendocrine - Tumour | ECE2019

Parafibromin is regulated by ubiquitin specific protease 37 (USP37) and the c-terminus of USP37 interacts with the beta-catenin binding region of CDC73 in hyperparathyroidism-jaw tumor syndrome

Kim Su Yeon , Lee Ji-young , Jo Kwan Hoon , Mo Eun Yeong , Kim Eun Sook , Han Je Ho , Baek Kwang-Hyun

CDC73 (also known as HRPT2) encodes parafibromin and is known to be the causative gene of hyperparathyroidism-jaw tumor (HPT-JT) syndrome. There is no known ubiquitination of parafibromin, and the deubiquitinating enzyme (DUB) for parafibromin has not been identified to date. Full-length DUB cDNAs encoding 58 family members of ubiquitin specific proteases (USPs) were subcloned. The DUB cDNA was used to identify parafibromin interacting by yeast two-hybrid screening. W...

ea0049ep554 | Diabetes complications | ECE2017

The association between pancreatic steatosis and diabetic retinopathy in patients with non-obese type 2 diabetes mellitus

Jeong Jee Sun , Kim Mee Kyung , do Han Kyung , Baek Ki-Hyun , Song Ki-Ho , Chung Dong Jin , Kwon Hyuk-Sang

Background: In the previous study, it was demonstrated that pancreatic steatosis was significantly associated with subclinical atherosclerosis in patients with non-obese T2DM. As the result, it was suggested that pancreatic steatosis might be related to macrovascular complication of T2DM. However, the association of pancreatic steatosis on microvascular complication of T2DM has been unknown.Objective: This study aimed to investigate the relation between ...

ea0049ep754 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Therapeutic potentials of small molecular weight allosteric agonist of relaxin receptor

Agoulnik Alexander , Agoulnik Irina , Hu Xin , Kaftanovskaya Elena , Huang Zaohua , Myhr Courtney , Xiao Jingbo , Soula Mariluz , Ho Brian , Barnaeva Elena , Southall Noel , Ferrer Marc , Marugan Juan

The anti-fibrotic, vasodilatory, and angiogenic therapeutic properties of relaxin peptide have been shown in several animal models of human diseases and in clinical trials. Using high-throughput screening of small molecule library, structure-activity relationship (SAR) studies, ligand-receptor interaction modeling, site-specific mutagenesis, and transgenic animal studies we discovered the first series of small molecule agonists of relaxin GPCR, RXFP1. The lead compound ML290 i...